RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX)

CUSIP: 75629V104

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Class A Common Stock
Shares outstanding
514,715,255
Total 13F shares
46,974,230
Share change
+46,974,200
Total reported value
$1,714,334,294
Price per share
$36.50
Number of holders
75
Value change
+$1,714,333,294
Number of buys
74

Quarterly Holders Quick Answers

What is CUSIP 75629V104?
CUSIP 75629V104 identifies RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) as of Q2 2021

As of 30 Jun 2021, RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) was held by 75 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,974,230 shares. The largest 10 holders included BAILLIE GIFFORD & CO, Laurion Capital Management LP, VANGUARD GROUP INC, ARK Investment Management LLC, FMR LLC, HARVARD MANAGEMENT CO INC, CREDIT SUISSE AG/, BlackRock Inc., MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC, and ALLIANCEBERNSTEIN L.P.. This page lists 75 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.